Abstract
ABSTRACT Background Incidence of MSCC is increasing, paralleling increasing life expectancy of patients (pts). We analyzed pts referred for surgery for MSCC to evaluate scoring system relevance, prognosis factors, efficiency and safety. Methods From 2004 to 2010 148 pts (77 men) with oncologic (84%) and hematological (16 %) diseases had surgery for MSCC. Patients and tumoral characteristics were recorded. Prognostic value of Tomita, Tokuhashi scores, ASA score, Frankel score (FS) and pain was investigated. Results Median age was 60 y (22–87). Lung (17%) and breast cancer (18%), were mainly represented. Multiple extra-bone metastases were observed in 39% of pts. Pain was present in 96% of pts and 66% were hyperalgic (pain score > 6). FS was decreased for 49% of pts and median Karnofsky Performance Scale (KPS) was 70%. Majority had laminectomy with spinal fixation: 73 %. Radiotherapy was done for 68%. Median overall survival (OS) was 8.9 months (IC95: 4.4–13). Tokuhashi but not Tomita score was relevant. Survival predictive accuracy of TS was only 51%. By univariate analyses, moderate pain (p = 0.001), primary breast (p = 0.02) or hematological (p 70 (p Conclusion Surgery for MSCC is associated with limited morbidity, improvement of patients' autonomy and remission of pain. In our study, usual scores seem not relevant, whereas ASA score, KPS and extra-bone metastases are significant survival prognostic factors. Disclosure All authors have declared no conflicts of interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.